LIST OF TABLES
UU
TABLE 1 CLINICAL TRIAL CONDUCTED IN DIFFERENT LOCATIONS 37
TABLE 2 TOP 20 PHARMA COMPANIES BY SIZE OF PIPELINE 43
TABLE 3 GLOBAL ECLINICAL SOLUTIONS MARKET, BY PRODUCT, 2017-2026 (USD MILLION) 55
TABLE 4 GLOBAL ELECTRONIC DATA CAPTURE (EDC) AND CLINICAL DATA MANAGEMENT SYSTEMS (CDMS) IN ECLINICAL SOLUTIONS MARKET, BY REGION, 2017-2026 (USD MILLION) 55
TABLE 5 GLOBAL RANDOMIZATION AND TRIAL SUPPLY MANAGEMENT (RTSM) IN ECLINICAL SOLUTIONS MARKET, BY REGION, 2017-2026 (USD MILLION) 56
TABLE 6 GLOBAL CLINICAL TRIAL MANAGEMENT SYSTEMS (CTMS) IN ECLINICAL SOLUTIONS MARKET, BY REGION, 2017-2026 (USD MILLION) 56
TABLE 7 GLOBAL ELECTRONIC CLINICAL OUTCOME ASSESSMENT (ECOA) IN ECLINICAL SOLUTIONS MARKET, BY REGION, 2017-2026 (USD MILLION) 57
TABLE 8 GLOBAL ELECTRICAL TRIAL MASTER FILE SYSTEM IN ECLINICAL SOLUTIONS MARKET, BY REGION, 2017-2026 (USD MILLION) 57
TABLE 9 GLOBAL SAFETY SOLUTIONS IN ECLINICAL SOLUTIONS MARKET, BY REGION, 2017-2026 (USD MILLION) 58
TABLE 10 GLOBAL REGULATORY INFORMATION MANAGEMENT SOLUTIONS IN ECLINICAL SOLUTIONS MARKET, BY REGION, 2017-2026 (USD MILLION) 58
TABLE 11 GLOBAL CLINICAL DATA INTEGRATION PLATFORMS IN ECLINICAL SOLUTIONS MARKET, BY REGION, 2017-2026 (USD MILLION) 59
TABLE 12 GLOBAL CLINICAL ANALYTICS PLATFORMS IN ECLINICAL SOLUTIONS MARKET, BY REGION, 2017-2026 (USD MILLION) 59
TABLE 13 GLOBAL OTHER ECLINICAL SOLUTIONS IN ECLINICAL SOLUTIONS MARKET, BY REGION, 2017-2026 (USD MILLION) 60
TABLE 14 GLOBAL ECLINICAL SOLUTIONS MARKET, BY DEPLOYMENT TYPE, 2017-2026 (USD MILLION) 62
TABLE 15 GLOBAL WEB-HOSTED (ON-DEMAND) SOLUTIONS IN ECLINICAL SOLUTIONS MARKET, BY REGION, 2017-2026 (USD MILLION) 63
TABLE 16 GLOBAL CLOUD-BASED (SAAS) SOLUTIONS IN ECLINICAL SOLUTIONS MARKET, BY REGION, 2017-2026 (USD MILLION) 63
TABLE 17 GLOBAL LICENSED ENTERPRISE (ON-PREMISE) SOLUTIONS IN ECLINICAL SOLUTIONS MARKET, BY REGION, 2017-2026 (USD MILLION) 64
TABLE 18 GLOBAL ECLINICAL SOLUTIONS MARKET, BY CLINICAL TRIAL PHASE, 2017-2026 (USD MILLION) 66
TABLE 19 GLOBAL PHASE III IN ECLINICAL SOLUTIONS MARKET, BY REGION, 2017-2026 (USD MILLION) 67
TABLE 20 GLOBAL PHASE II IN ECLINICAL SOLUTIONS MARKET, BY REGION, 2017-2026 (USD MILLION) 67
TABLE 21 GLOBAL PHASE IV IN ECLINICAL SOLUTIONS MARKET, BY REGION, 2017-2026 (USD MILLION) 68
TABLE 22 GLOBAL PHASE I IN ECLINICAL SOLUTIONS MARKET, BY REGION, 2017-2026 (USD MILLION) 68
TABLE 23 GLOBAL ECLINICAL SOLUTIONS MARKET, BY END USER, 2017-2026 (USD MILLION) 71
TABLE 24 GLOBAL HOSPITALS/HEALTHCARE PROVIDERS IN ECLINICAL SOLUTIONS MARKET, BY REGION, 2017-2026 (USD MILLION) 71
TABLE 25 GLOBAL CONTRACT RESEARCH ORGANIZATIONS (CROS) IN ECLINICAL SOLUTIONS MARKET, BY REGION, 2017-2026 (USD MILLION) 72
TABLE 26 GLOBAL ACADEMIC INSTITUTES COMPANIES IN ECLINICAL SOLUTIONS MARKET, BY REGION, 2017-2026 (USD MILLION) 72
TABLE 27 GLOBAL PHARMA & BIOTECH ORGANIZATIONS IN ECLINICAL SOLUTIONS MARKET, BY REGION, 2017-2026 (USD MILLION) 73
TABLE 28 GLOBAL MEDICAL DEVICE MANUFACTURERS IN ECLINICAL SOLUTIONS MARKET, BY REGION, 2017-2026 (USD MILLION) 73
TABLE 29 GLOBAL CONSULTING SERVICE COMPANIES IN ECLINICAL SOLUTIONS MARKET, BY REGION, 2017-2026 (USD MILLION) 74
TABLE 30 GLOBAL ECLINICAL SOLUTIONS MARKET, BY REGION, 2017-2026 (USD MILLION) 80
TABLE 31 NORTH AMERICA ECLINICAL SOLUTIONS MARKET, BY REGION, 2017-2026 (USD MILLION) 84
TABLE 32 NORTH AMERICA ECLINICAL SOLUTIONS MARKET, BY PRODUCT, 2017-2026 (USD MILLION) 84
TABLE 33 NORTH AMERICA ECLINICAL SOLUTIONS MARKET, BY DEPLOYMENT TYPE, 2017-2026 (USD MILLION) 84
TABLE 34 NORTH AMERICA ECLINICAL SOLUTIONS MARKET, BY CLINICAL TRIAL PHASE, 2017-2026 (USD MILLION) 85
TABLE 35 NORTH AMERICA ECLINICAL SOLUTIONS MARKET, BY END USER, 2017-2026 (USD MILLION) 85
TABLE 36 U.S. ECLINICAL SOLUTIONS MARKET, BY PRODUCT, 2017-2026 (USD MILLION) 86
TABLE 37 U.S. ECLINICAL SOLUTIONS MARKET, BY DEPLOYMENT TYPE, 2017-2026 (USD MILLION) 86
TABLE 38 U.S. ECLINICAL SOLUTIONS MARKET, BY CLINICAL TRIAL PHASE, 2017-2026 (USD MILLION) 86
TABLE 39 U.S. ECLINICAL SOLUTIONS MARKET, BY END USER, 2017-2026 (USD MILLION) 87
TABLE 40 CANADA ECLINICAL SOLUTIONS MARKET, BY PRODUCT, 2017-2026 (USD MILLION) 88
TABLE 41 CANADA ECLINICAL SOLUTIONS MARKET, BY DEPLOYMENT TYPE, 2017-2026 (USD MILLION) 88
TABLE 42 CANADA ECLINICAL SOLUTIONS MARKET, BY CLINICAL TRIAL PHASE, 2017-2026 (USD MILLION) 88
TABLE 43 CANADA ECLINICAL SOLUTIONS MARKET, BY END USER, 2017-2026 (USD MILLION) 89
TABLE 44 MEXICO ECLINICAL SOLUTIONS MARKET, BY PRODUCT, 2017-2026 (USD MILLION) 90
TABLE 45 MEXICO ECLINICAL SOLUTIONS MARKET, BY DEPLOYMENT TYPE, 2017-2026 (USD MILLION) 90
TABLE 46 MEXICO ECLINICAL SOLUTIONS MARKET, BY CLINICAL TRIAL PHASE, 2017-2026 (USD MILLION) 90
TABLE 47 MEXICO ECLINICAL SOLUTIONS MARKET, BY END USER, 2017-2026 (USD MILLION) 91
TABLE 48 EUROPE ECLINICAL SOLUTIONS MARKET, BY COUNTRY, 2017-2026 (USD MILLION) 95
TABLE 49 EUROPE ECLINICAL SOLUTIONS MARKET, BY PRODUCT, 2017-2026 (USD MILLION) 95
TABLE 50 EUROPE ECLINICAL SOLUTIONS MARKET, BY DEPLOYMENT TYPE, 2017-2026 (USD MILLION) 96
TABLE 51 EUROPE ECLINICAL SOLUTIONS MARKET, BY CLINICAL TRIAL PHASE, 2017-2026 (USD MILLION) 96
TABLE 52 EUROPE ECLINICAL SOLUTIONS MARKET, BY END USER, 2017-2026 (USD MILLION) 96
TABLE 53 GERMANY ECLINICAL SOLUTIONS MARKET, BY PRODUCT, 2017-2026 (USD MILLION) 97
TABLE 54 GERMANY ECLINICAL SOLUTIONS MARKET, BY DEPLOYMENT TYPE, 2017-2026 (USD MILLION) 97
TABLE 55 GERMANY ECLINICAL SOLUTIONS MARKET, BY CLINICAL TRIAL PHASE, 2017-2026 (USD MILLION) 97
TABLE 56 GERMANY ECLINICAL SOLUTIONS MARKET, BY END USER, 2017-2026 (USD MILLION) 98
TABLE 57 U.K. ECLINICAL SOLUTIONS MARKET, BY PRODUCT, 2017-2026 (USD MILLION) 99
TABLE 58 U.K. ECLINICAL SOLUTIONS MARKET, BY DEPLOYMENT TYPE, 2017-2026 (USD MILLION) 99
TABLE 59 U.K. ECLINICAL SOLUTIONS MARKET, BY CLINICAL TRIAL PHASE, 2017-2026 (USD MILLION) 99
TABLE 60 U.K. ECLINICAL SOLUTIONS MARKET, BY END USER, 2017-2026 (USD MILLION) 100
TABLE 61 ITALY ECLINICAL SOLUTIONS MARKET, BY PRODUCT, 2017-2026 (USD MILLION) 101
TABLE 62 ITALY ECLINICAL SOLUTIONS MARKET, BY DEPLOYMENT TYPE, 2017-2026 (USD MILLION) 101
TABLE 63 ITALY ECLINICAL SOLUTIONS MARKET, BY CLINICAL TRIAL PHASE, 2017-2026 (USD MILLION) 101
TABLE 64 ITALY ECLINICAL SOLUTIONS MARKET, BY END USER, 2017-2026 (USD MILLION) 102
TABLE 65 FRANCE ECLINICAL SOLUTIONS MARKET, BY PRODUCT, 2017-2026 (USD MILLION) 103
TABLE 66 FRANCE ECLINICAL SOLUTIONS MARKET, BY DEPLOYMENT TYPE, 2017-2026 (USD MILLION) 103
TABLE 67 FRANCE ECLINICAL SOLUTIONS MARKET, BY CLINICAL TRIAL PHASE, 2017-2026 (USD MILLION) 103
TABLE 68 FRANCE ECLINICAL SOLUTIONS MARKET, BY END USER, 2017-2026 (USD MILLION) 104
TABLE 69 RUSSIA ECLINICAL SOLUTIONS MARKET, BY PRODUCT, 2017-2026 (USD MILLION) 105
TABLE 70 RUSSIA ECLINICAL SOLUTIONS MARKET, BY DEPLOYMENT TYPE, 2017-2026 (USD MILLION) 105
TABLE 71 RUSSIA ECLINICAL SOLUTIONS MARKET, BY CLINICAL TRIAL PHASE, 2017-2026 (USD MILLION) 105
TABLE 72 RUSSIA ECLINICAL SOLUTIONS MARKET, BY END USER, 2017-2026 (USD MILLION) 106
TABLE 73 SWITZERLAND ECLINICAL SOLUTIONS MARKET, BY PRODUCT, 2017-2026 (USD MILLION) 107
TABLE 74 SWITZERLAND ECLINICAL SOLUTIONS MARKET, BY DEPLOYMENT TYPE, 2017-2026 (USD MILLION) 107
TABLE 75 SWITZERLAND ECLINICAL SOLUTIONS MARKET, BY CLINICAL TRIAL PHASE, 2017-2026 (USD MILLION) 107
TABLE 76 SWITZERLAND ECLINICAL SOLUTIONS MARKET, BY END USER, 2017-2026 (USD MILLION) 108
TABLE 77 NETHERLANDS ECLINICAL SOLUTIONS MARKET, BY PRODUCT, 2017-2026 (USD MILLION) 109
TABLE 78 NETHERLANDS ECLINICAL SOLUTIONS MARKET, BY DEPLOYMENT TYPE, 2017-2026 (USD MILLION) 109
TABLE 79 NETHERLANDS ECLINICAL SOLUTIONS MARKET, BY CLINICAL TRIAL PHASE, 2017-2026 (USD MILLION) 109
TABLE 80 NETHERLANDS ECLINICAL SOLUTIONS MARKET, BY END USER, 2017-2026 (USD MILLION) 110
TABLE 81 SPAIN ECLINICAL SOLUTIONS MARKET, BY PRODUCT, 2017-2026 (USD MILLION) 111
TABLE 82 SPAIN ECLINICAL SOLUTIONS MARKET, BY DEPLOYMENT TYPE, 2017-2026 (USD MILLION) 111
TABLE 83 SPAIN ECLINICAL SOLUTIONS MARKET, BY CLINICAL TRIAL PHASE, 2017-2026 (USD MILLION) 111
TABLE 84 SPAIN ECLINICAL SOLUTIONS MARKET, BY END USER, 2017-2026 (USD MILLION) 112
TABLE 85 TURKEY ECLINICAL SOLUTIONS MARKET, BY PRODUCT, 2017-2026 (USD MILLION) 113
TABLE 86 TURKEY ECLINICAL SOLUTIONS MARKET, BY DEPLOYMENT TYPE, 2017-2026 (USD MILLION) 113
TABLE 87 TURKEY ECLINICAL SOLUTIONS MARKET, BY CLINICAL TRIAL PHASE, 2017-2026 (USD MILLION) 113
TABLE 88 TURKEY ECLINICAL SOLUTIONS MARKET, BY END USER, 2017-2026 (USD MILLION) 113
TABLE 89 BELGIUM ECLINICAL SOLUTIONS MARKET, BY PRODUCT, 2017-2026 (USD MILLION) 115
TABLE 90 BELGIUM ECLINICAL SOLUTIONS MARKET, BY DEPLOYMENT TYPE, 2017-2026 (USD MILLION) 115
TABLE 91 BELGIUM ECLINICAL SOLUTIONS MARKET, BY CLINICAL TRIAL PHASE, 2017-2026 (USD MILLION) 115
TABLE 92 BELGIUM ECLINICAL SOLUTIONS MARKET, BY END USER, 2017-2026 (USD MILLION) 116
TABLE 93 REST OF EUROPE ECLINICAL SOLUTIONS MARKET, BY PRODUCT, 2017-2026 (USD MILLION) 117
TABLE 94 ASIA-PACIFIC ECLINICAL SOLUTIONS MARKET, BY COUNTRY, 2017-2026 (USD MILLION) 121
TABLE 95 ASIA-PACIFIC ECLINICAL SOLUTIONS MARKET, BY PRODUCT, 2017-2026 (USD MILLION) 121
TABLE 96 ASIA-PACIFIC ECLINICAL SOLUTIONS MARKET, BY DEPLOYMENT TYPE, 2017-2026 (USD MILLION) 122
TABLE 97 ASIA-PACIFIC ECLINICAL SOLUTIONS MARKET, BY CLINICAL TRIAL PHASE, 2017-2026 (USD MILLION) 122
TABLE 98 ASIA-PACIFIC ECLINICAL SOLUTIONS MARKET, BY END USER, 2017-2026 (USD MILLION) 122
TABLE 99 JAPAN ECLINICAL SOLUTIONS MARKET, BY PRODUCT, 2017-2026 (USD MILLION) 123
TABLE 100 JAPAN ECLINICAL SOLUTIONS MARKET, BY DEPLOYMENT TYPE, 2017-2026 (USD MILLION) 123
TABLE 101 JAPAN ECLINICAL SOLUTIONS MARKET, BY CLINICAL TRIAL PHASE, 2017-2026 (USD MILLION) 123
TABLE 102 JAPAN ECLINICAL SOLUTIONS MARKET, BY END USER, 2017-2026 (USD MILLION) 124
TABLE 103 CHINA ECLINICAL SOLUTIONS MARKET, BY PRODUCT, 2017-2026 (USD MILLION) 125
TABLE 104 CHINA ECLINICAL SOLUTIONS MARKET, BY DEPLOYMENT TYPE, 2017-2026 (USD MILLION) 125
TABLE 105 CHINA ECLINICAL SOLUTIONS MARKET, BY CLINICAL TRIAL PHASE, 2017-2026 (USD MILLION) 125
TABLE 106 CHINA ECLINICAL SOLUTIONS MARKET, BY END USER, 2017-2026 (USD MILLION) 126
TABLE 107 INDIA ECLINICAL SOLUTIONS MARKET, BY PRODUCT, 2017-2026 (USD MILLION) 127
TABLE 108 INDIA ECLINICAL SOLUTIONS MARKET, BY DEPLOYMENT TYPE, 2017-2026 (USD MILLION) 127
TABLE 109 INDIA ECLINICAL SOLUTIONS MARKET, BY CLINICAL TRIAL PHASE, 2017-2026 (USD MILLION) 127
TABLE 110 INDIA ECLINICAL SOLUTIONS MARKET, BY END USER, 2017-2026 (USD MILLION) 127
TABLE 111 SOUTH KOREA ECLINICAL SOLUTIONS MARKET, BY PRODUCT, 2017-2026 (USD MILLION) 129
TABLE 112 SOUTH KOREA ECLINICAL SOLUTIONS MARKET, BY DEPLOYMENT TYPE, 2017-2026 (USD MILLION) 129
TABLE 113 SOUTH KOREA ECLINICAL SOLUTIONS MARKET, BY CLINICAL TRIAL PHASE, 2017-2026 (USD MILLION) 129
TABLE 114 SOUTH KOREA ECLINICAL SOLUTIONS MARKET, BY END USER, 2017-2026 (USD MILLION) 130
TABLE 115 AUSTRALIA ECLINICAL SOLUTIONS MARKET, BY PRODUCT, 2017-2026 (USD MILLION) 131
TABLE 116 AUSTRALIA ECLINICAL SOLUTIONS MARKET, BY DEPLOYMENT TYPE, 2017-2026 (USD MILLION) 131
TABLE 117 AUSTRALIA ECLINICAL SOLUTIONS MARKET, BY CLINICAL TRIAL PHASE, 2017-2026 (USD MILLION) 131
TABLE 118 AUSTRALIA ECLINICAL SOLUTIONS MARKET, BY END USER, 2017-2026 (USD MILLION) 132
TABLE 119 SINGAPORE ECLINICAL SOLUTIONS MARKET, BY PRODUCT, 2017-2026 (USD MILLION) 133
TABLE 120 SINGAPORE ECLINICAL SOLUTIONS MARKET, BY DEPLOYMENT TYPE, 2017-2026 (USD MILLION) 133
TABLE 121 SINGAPORE ECLINICAL SOLUTIONS MARKET, BY CLINICAL TRIAL PHASE, 2017-2026 (USD MILLION) 133
TABLE 122 SINGAPORE ECLINICAL SOLUTIONS MARKET, BY END USER, 2017-2026 (USD MILLION) 134
TABLE 123 THIALAND ECLINICAL SOLUTIONS MARKET, BY PRODUCT, 2017-2026 (USD MILLION) 135
TABLE 124 THIALAND ECLINICAL SOLUTIONS MARKET, BY DEPLOYMENT TYPE, 2017-2026 (USD MILLION) 135
TABLE 125 THIALAND ECLINICAL SOLUTIONS MARKET, BY CLINICAL TRIAL PHASE, 2017-2026 (USD MILLION) 135
TABLE 126 THIALAND ECLINICAL SOLUTIONS MARKET, BY END USER, 2017-2026 (USD MILLION) 136
TABLE 127 MALAYSIA ECLINICAL SOLUTIONS MARKET, BY PRODUCT, 2017-2026 (USD MILLION) 137
TABLE 128 MALAYSIA ECLINICAL SOLUTIONS MARKET, BY DEPLOYMENT TYPE, 2017-2026 (USD MILLION) 137
TABLE 129 MALAYSIA ECLINICAL SOLUTIONS MARKET, BY CLINICAL TRIAL PHASE, 2017-2026 (USD MILLION) 137
TABLE 130 MALAYSIA ECLINICAL SOLUTIONS MARKET, BY END USER, 2017-2026 (USD MILLION) 138
TABLE 131 INDONESIA ECLINICAL SOLUTIONS MARKET, BY PRODUCT, 2017-2026 (USD MILLION) 139
TABLE 132 INDONESIA ECLINICAL SOLUTIONS MARKET, BY DEPLOYMENT TYPE, 2017-2026 (USD MILLION) 139
TABLE 133 INDONESIA ECLINICAL SOLUTIONS MARKET, BY CLINICAL TRIAL PHASE, 2017-2026 (USD MILLION) 139
TABLE 134 INDONESIA ECLINICAL SOLUTIONS MARKET, BY END USER, 2017-2026 (USD MILLION) 140
TABLE 135 PHILIPPINES ECLINICAL SOLUTIONS MARKET, BY PRODUCT, 2017-2026 (USD MILLION) 141
TABLE 136 PHILIPPINES ECLINICAL SOLUTIONS MARKET, BY DEPLOYMENT TYPE, 2017-2026 (USD MILLION) 141
TABLE 137 PHILIPPINES ECLINICAL SOLUTIONS MARKET, BY CLINICAL TRIAL PHASE, 2017-2026 (USD MILLION) 141
TABLE 138 PHILIPPINES ECLINICAL SOLUTIONS MARKET, BY END USER, 2017-2026 (USD MILLION) 142
TABLE 139 REST OF ASIA-PACIFIC ECLINICAL SOLUTIONS MARKET, BY PRODUCT, 2017-2026 (USD MILLION) 143
TABLE 140 SOUTH AMERICA ECLINICAL SOLUTIONS MARKET, BY COUNTRY, 2017-2026 (USD MILLION) 147
TABLE 141 SOUTH AMERICA ECLINICAL SOLUTIONS MARKET, BY PRODUCT, 2017-2026 (USD MILLION) 147
TABLE 142 SOUTH AMERICA ECLINICAL SOLUTIONS MARKET, BY DEPLOYMENT TYPE, 2017-2026 (USD MILLION) 147
TABLE 143 SOUTH AMERICA ECLINICAL SOLUTIONS MARKET, BY CLINICAL TRIAL PHASE, 2017-2026 (USD MILLION) 148
TABLE 144 SOUTH AMERICA ECLINICAL SOLUTIONS MARKET, BY END USER, 2017-2026 (USD MILLION) 148
TABLE 145 BRAZIL ECLINICAL SOLUTIONS MARKET, BY PRODUCT, 2017-2026 (USD MILLION) 149
TABLE 146 BRAZIL ECLINICAL SOLUTIONS MARKET, BY DEPLOYMENT TYPE, 2017-2026 (USD MILLION) 149
TABLE 147 BRAZL ECLINICAL SOLUTIONS MARKET, BY CLINICAL TRIAL PHASE, 2017-2026 (USD MILLION) 149
TABLE 148 BRAZIL ECLINICAL SOLUTIONS MARKET, BY END USER, 2017-2026 (USD MILLION) 150
TABLE 149 REST OF SOUTH AMERICA ECLINICAL SOLUTIONS MARKET, BY PRODUCT, 2017-2026 (USD MILLION) 151
TABLE 150 MIDDLE EAST AND AFRICA ECLINICAL SOLUTIONS MARKET, BY COUNTRY, 2017-2026 (USD MILLION) 155
TABLE 151 MIDDLE EAST AND AFRICA ECLINICAL SOLUTIONS MARKET, BY PRODUCT, 2017-2026 (USD MILLION) 155
TABLE 152 MIDDLE EAST AND AFRICA ECLINICAL SOLUTIONS MARKET, BY DEPLOYMENT TYPE, 2017-2026 (USD MILLION) 155
TABLE 153 MIDDLE EAST AND AFRICA ECLINICAL SOLUTIONS MARKET, BY CLINICAL TRIAL PHASE, 2017-2026 (USD MILLION) 156
TABLE 154 MIDDLE EAST AND AFRICA ECLINICAL SOLUTIONS MARKET, BY END USER, 2017-2026 (USD MILLION) 156
TABLE 155 SOUTH AFRICA ECLINICAL SOLUTIONS MARKET, BY PRODUCT, 2017-2026 (USD MILLION) 157
TABLE 156 SOUTH AFRICA ECLINICAL SOLUTIONS MARKET, BY DEPLOYMENT TYPE, 2017-2026 (USD MILLION) 157
TABLE 157 SOUTH AFRICA ECLINICAL SOLUTIONS MARKET, BY CLINICAL TRIAL PHASE, 2017-2026 (USD MILLION) 158
TABLE 158 SOUTH AFRICA ECLINICAL SOLUTIONS MARKET, BY END USER, 2017-2026 (USD MILLION) 158
TABLE 159 REST OF MIDDLE EAST AND AFRICA ECLINICAL SOLUTIONS MARKET, BY PRODUCT, 2017-2026 (USD MILLION) 159

LIST OF FIGURE

LIST OF FIGURES

FIGURE 1 GLOBAL ECLINICAL SOLUTIONS MARKET: SEGMENTATION 25
FIGURE 2 GLOBAL ECLINICAL SOLUTIONS MARKET: DATA TRIANGULATION 28
FIGURE 3 GLOBAL ECLINICAL SOLUTIONS MARKET: DROC ANALYSIS 29
FIGURE 4 GLOBAL ECLINICAL SOLUTIONS MARKET: GLOBAL VS REGIONAL MARKET ANALYSIS 30
FIGURE 5 GLOBAL ECLINICAL SOLUTIONS MARKET: COMPANY RESEARCH ANALYSIS 30
FIGURE 6 GLOBAL ECLINICAL SOLUTIONS MARKET: INTERVIEW DEMOGRAPHICS 31
FIGURE 7 GLOBAL ECLINICAL SOLUTIONS MARKET: DBMR MARKET POSITION GRID 32
FIGURE 8 DRIVERS, RESTRAINTS, OPPORTUNITIES AND CHALLENGE OF THE GLOBAL ECLINICAL SOLUTIONS MARKET 36
FIGURE 9 CLINICAL TRIAL CONDUCTED PER YEAR 38
FIGURE 10 THE MARKET GROWTH IN CLINICAL CRO (IN USD MILLIONS) 40
FIGURE 11 THE FUNCTION OF CRO 41
FIGURE 12 WORLDWIDE BIOPHARMA COMPANIES R&D EXPENDITURE (IN MILLION U.S. DOLLARS) 42
FIGURE 13 ECLINICAL ENTERPRISE PRICING PACKAGES 45
FIGURE 14 COMPARISON OF TECHNOLOGIES USED BY CROS IN CLINICAL RESEARCH PROCESS 47
FIGURE 15 GLOBAL ECLINICAL SOLUTIONS MARKET: SEGMENTATION 50
FIGURE 16 GROWING NUMBER OF CONTRACT RESEARCH ORGANIZATION AND RISING GOVERNMENT INITITAIVES ARE EXPECTED TO DRIVE THE GLOBAL ECLINICAL SOLUTIONS MARKET IN THE FORECAST PERIOD OF 2019 TO 2026 51
FIGURE 17 ELECTRONIC DATA CAPTURE (EDC) AND CLINICAL DATA MANAGEMENT SYSTEMS (CDMS) IS EXPECTED TO ACCOUNT FOR THE LARGEST SHARE OF THE GLOBAL ECLINICAL SOLUTIONS MARKET IN 2019 51
FIGURE 18 ASIA-PACIFIC IS THE MAXIMUM GROWING AND NORTH AMERICA IS THE MOST PROFITABLE REVENUE POCKETS FOR GLOBAL ECLINICAL SOLUTIONS MARKET IN THE FORECAST PERIOD OF 2019 TO 2026 52
FIGURE 19 GLOBAL ECLINICAL SOLUTIONS MARKET: BY PRODUCT (2018) 54
FIGURE 20 GLOBAL ECLINICAL SOLUTIONS MARKET: BY DEPLOYMENT TYPE (2018) 62
FIGURE 21 GLOBAL ECLINICAL SOLUTIONS MARKET: BY CLINICAL TRIAL PHASE (2018) 66
FIGURE 22 GLOBAL ECLINICAL SOLUTIONS MARKET: BY END USER (2018) 70
FIGURE 23 GLOBAL ECLINICAL SOLUTIONS MARKET: SNAPSHOT (2018) 77
FIGURE 24 GLOBAL ECLINICAL SOLUTIONS MARKET: BY COUNTRY (2018) 78
FIGURE 25 GLOBAL ECLINICAL SOLUTIONS MARKET: BY COUNTRY (2019 & 2026) 78
FIGURE 26 GLOBAL ECLINICAL SOLUTIONS MARKET: BY COUNTRY (2018 & 2026) 79
FIGURE 27 GLOBAL ECLINICAL SOLUTIONS MARKET: BY PRODUCT (2019-2026) 79
FIGURE 28 NORTH AMERICA ECLINICAL SOLUTIONS MARKET: SNAPSHOT (2018) 81
FIGURE 29 NORTH AMERICA ECLINICAL SOLUTIONS MARKET: BY COUNTRY (2018) 82
FIGURE 30 NORTH AMERICA ECLINICAL SOLUTIONS MARKET: BY COUNTRY (2019 & 2026) 82
FIGURE 31 NORTH AMERICA ECLINICAL SOLUTIONS MARKET: BY COUNTRY (2018 & 2026) 83
FIGURE 32 NORTH AMERICA ECLINICAL SOLUTIONS MARKET: BY PRODUCT (2019-2026) 83
FIGURE 33 EUROPE ECLINICAL SOLUTIONS MARKET: SNAPSHOT (2018) 92
FIGURE 34 EUROPE ECLINICAL SOLUTIONS MARKET: BY COUNTRY (2018) 93
FIGURE 35 EUROPE ECLINICAL SOLUTIONS MARKET: BY COUNTRY (2019 & 2026) 93
FIGURE 36 EUROPE ECLINICAL SOLUTIONS MARKET: BY COUNTRY (2018 & 2026) 94
FIGURE 37 EUROPE ECLINICAL SOLUTIONS MARKET: BY PRODUCT (2019-2026) 94
FIGURE 38 ASIA-PACIFIC ECLINICAL SOLUTIONS MARKET: SNAPSHOT (2018) 118
FIGURE 39 ASIA-PACIFIC ECLINICAL SOLUTIONS MARKET: BY COUNTRY (2018) 119
FIGURE 40 ASIA-PACIFIC ECLINICAL SOLUTIONS MARKET: BY COUNTRY (2019 & 2026) 119
FIGURE 41 ASIA-PACIFIC ECLINICAL SOLUTIONS MARKET: BY COUNTRY (2018 & 2026) 120
FIGURE 42 ASIA-PACIFIC ECLINICAL SOLUTIONS MARKET: BY PRODUCT (2019-2026) 120
FIGURE 43 SOUTH AMERICA ECLINICAL SOLUTIONS MARKET: SNAPSHOT (2018) 144
FIGURE 44 SOUTH AMERICA ECLINICAL SOLUTIONS MARKET: BY COUNTRY (2018) 145
FIGURE 45 SOUTH AMERICA ECLINICAL SOLUTIONS MARKET: BY COUNTRY (2019 & 2026) 145
FIGURE 46 SOUTH AMERICA ECLINICAL SOLUTIONS MARKET: BY COUNTRY (2018 & 2026) 146
FIGURE 47 SOUTH AMERICA ECLINICAL SOLUTIONS MARKET: BY PRODUCT (2019-2026) 146
FIGURE 48 MIDDLE EAST AND AFRICA ECLINICAL SOLUTIONS MARKET: SNAPSHOT (2018) 152
FIGURE 49 MIDDLE EAST AND AFRICA ECLINICAL SOLUTIONS MARKET: BY COUNTRY (2018) 153
FIGURE 50 MIDDLE EAST AND AFRICA SOLUTIONS MARKET: BY COUNTRY (2019 & 2026) 153
FIGURE 51 MIDDLE EAST AND AFRICA ECLINICAL SOLUTIONS MARKET: BY COUNTRY (2018 & 2026) 154
FIGURE 52 MIDDLE EAST AND AFRICA ECLINICAL SOLUTIONS MARKET: BY PRODUCT (2019-2026) 154
FIGURE 53 GLOBAL ECLINICAL SOLUTIONS MARKET: COMPANY SHARE 2018 (%) 160
FIGURE 54 NORTH AMERICA INFLATION DEVICE MARKET: COMPANY SHARE 2018 (%) 161
FIGURE 55 EUROPE INFLATION DEVICE MARKET: COMPANY SHARE 2018 (%) 162
FIGURE 56 ASIA PACIFIC INFLATION DEVICE MARKET: COMPANY SHARE 2018 (%) 163